on The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group Discloses Significant Stake in Mural Oncology
On June 5, 2025, The Vanguard Group, Inc. released a Form 8.3 announcement regarding its stake in Mural Oncology plc. As a participant under Rule 8.3 of the Irish Takeover Panel Act, The Vanguard Group has revealed its interests in Mural Oncology’s securities.
The disclosed holdings consist of 772,883 ordinary shares, which represent a 4.48% interest in Mural Oncology. On June 4, 2025, the firm also executed a minor sale of 16 shares at a price of 2.59 USD per share.
The disclosure confirms no involvement in derivatives or agreements influencing Mural Oncology's securities, and there are no indemnity or option arrangements. The announcement follows standard protocols for transparency during the takeover process.
R. H.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all The Vanguard Group, Inc. news